tetraspanin
protein
ubiquit
express
consist
transmembran
domain
intracellular
terminu
extracellular
loop
tetraspanin
function
organ
cell
surfac
recruit
specif
partner
protein
tetraspaninenrich
microdomain
tem
bring
togeth
larg
varieti
molecul
amplifi
activ
tetraspanin
regul
variou
cellular
process
cell
adhes
motil
growth
differenti
signal
transduct
fusion
summar
tabl
also
known
leukemiaassoci
cell
surfac
antigen
motilityrel
member
tetraspanin
superfamili
first
identifi
kersey
et
al
human
lymphohematopoiet
progenitor
cell
surfac
antigen
use
monoclon
antibodi
bound
acut
lymphoblast
leukemia
cell
character
reveal
express
larg
varieti
hematopoiet
nonhematopoiet
cell
stromal
cell
megakaryocyt
platelet
b
lymphocyt
dendrit
cell
endotheli
cell
mast
cell
eosinophil
basophil
tetraspanin
first
describ
motilityrel
factor
subsequ
associ
variou
integrin
adhes
receptor
regul
cell
migrat
invas
homozyg
adult
mice
exhibit
obviou
abnorm
howev
mice
intercross
fertil
sever
reduc
thu
appear
essenti
spermegg
bind
fusion
exact
mechan
still
fulli
understood
local
microvillar
region
oocyt
may
necessari
organ
multiprotein
complex
studi
highlight
interact
membran
protein
necessari
fertil
pregnanc
specif
glycoprotein
waterhous
jexpm
integrin
chen
pna
interact
integrin
seem
essenti
strong
adhes
sperm
oocyt
inou
develip
may
play
also
role
gener
fusion
compet
site
egg
membran
requir
fusion
spermadhes
strengthen
pna
regard
patholog
model
suppress
invas
metastat
capac
breast
cancer
cell
mous
xenograft
defici
reduc
sever
osteoarthr
age
antigeninduc
arthriti
model
howev
defici
also
induc
phenotyp
similar
human
chronic
obstruct
pulmonari
diseas
copd
report
clearli
suggest
crucial
control
inflamm
support
role
modul
humor
immun
respons
product
myeloid
cell
secret
cytokin
macrophag
present
hematopoiet
cell
well
cell
regul
activ
bone
marrow
critic
hematopoiesi
event
figur
thu
express
nearli
bone
marrow
cell
rang
express
vari
low
high
level
accord
degre
cell
differenti
earli
b
cell
express
high
level
correl
presenc
earli
megakaryocyt
marker
indic
cell
highest
level
commit
blymphoid
megakaryocyt
lineag
earli
increas
express
megakaryopoiesi
suggest
may
play
role
megakaryocyt
differenti
particip
membran
remodel
process
inde
antibodi
ligat
alter
vitro
differenti
human
cell
megakaryocyt
product
myeloid
cell
longterm
bone
marrow
cultur
block
addit
ligat
promot
adhes
myeloid
stromal
cell
final
pluripot
hematopoiet
cell
cultur
stromal
cell
presenc
migrat
beneath
adher
stromal
cell
layer
undifferenti
properti
altogeth
data
demonstr
stromal
cell
express
influenc
physic
interact
hematopoiet
cell
may
one
factor
determin
degre
stem
cell
differenti
abundantli
express
plasma
membran
differ
myeloid
lineag
cell
mast
cell
basophil
eosinophil
macrophag
role
cytokinemedi
chemotact
respons
human
mast
cell
chemotaxi
mast
cell
toward
abrog
antibodi
decreas
express
use
rna
interfer
result
demonstr
act
substitut
receptor
moreov
induc
nonimmunoglobulin
e
ige
mediat
mast
cell
activ
mast
cell
coloc
highaffin
ige
receptor
nontcel
activ
linker
ntal
antibodymedi
crosslink
activ
mast
cell
caus
degranul
calcium
releas
tyrosin
phosphoryl
variou
protein
ntal
thu
activ
mast
cell
differ
way
stem
cell
factor
ige
mediat
also
express
basophil
manner
mast
cell
antibodi
crosslink
stimul
degranul
model
rat
basophil
leukemia
cell
transfect
human
cell
degranul
respons
antibodi
colig
express
featur
eosinophil
platelet
antibodi
crosslink
activ
degranul
eosinophil
platelet
integrin
fccriia
respect
interestingli
crosslink
induc
eosinophil
degranul
enhanc
surviv
local
mhc
class
ii
eosinophil
plasma
membran
necessari
abil
eosinophil
trigger
tcell
activ
prolifer
cytokin
product
final
stimul
eosinophil
trigger
releas
process
vesicular
transport
suggest
possibl
function
temper
celldepend
inflammatori
respons
interestingli
antibodi
induc
platelet
aggreg
granul
releas
depend
fccriia
although
signal
gener
distinct
fccriia
activ
alon
contrast
neutrophil
degranul
provok
blockad
consist
lack
express
neutrophil
tetraspanin
express
differenti
monocyt
subset
higher
level
subset
monocyt
matur
monocyt
result
increas
express
even
higher
level
present
monocytederiv
macrophag
furthermor
express
monocytederiv
macrophag
stimul
mcsf
decreas
infect
howev
suzuki
et
al
describ
neg
regul
lipopolysaccharideinduc
macrophag
activ
lung
inflamm
delet
mice
enhanc
macrophag
infiltr
product
lung
intranas
administr
lp
vivo
consist
immun
cell
describ
antibodi
activ
macrophag
treatment
mous
macrophag
induc
protein
tyrosin
phosphoryl
filopodium
extens
cell
aggreg
caus
cocrosslink
function
associ
modifi
signal
phagocytosi
inflammatori
respons
final
associ
surfac
macrophag
lead
foam
cell
format
respons
oxid
lowdens
lipoprotein
togeth
data
demonstr
crosslink
induc
mast
cell
basophil
eosinophil
platelet
activ
lead
degranul
also
stimul
rang
activ
chemotaxi
cytokin
releas
figur
activ
macrophag
also
occur
via
crosslink
allow
regul
inflamm
coexpress
coloc
human
dendrit
cell
dc
shown
peng
et
al
flow
cytometri
confoc
microscopi
immunoprecipitationimmunoblot
experi
figur
concomit
activ
crosslink
result
increas
product
highlight
function
cooper
also
dc
mhcii
molecul
physic
associ
tem
highlight
coimmunoprecipit
cocap
experi
integr
lipid
raft
necessari
hladr
signal
activ
respect
dc
function
knockout
dc
induc
reduc
level
tcell
activ
wildtyp
dc
effect
relat
reduct
mhcii
surfac
express
dc
due
impair
exocytosi
intern
also
block
demonstr
specif
regul
antigen
present
dc
regul
mhcii
intracellular
traffick
dendrit
cell
releas
larg
quantiti
exosom
known
dexosom
amplifi
adapt
tcell
innat
natur
killer
cell
cellular
immun
respons
dexosom
compris
characterist
set
protein
includ
known
antigenpres
molecul
mhci
ii
b
c
costimulatori
molecul
crosslink
thu
activ
dc
lead
cytokin
product
necessari
antigen
present
essenti
regul
inflamm
dc
convent
b
cell
express
earli
stage
differenti
lost
reexpress
b
cell
activ
physic
link
tetraspan
figur
inde
coimmunoprecipit
lysat
cell
line
purifi
earli
b
cell
line
physic
interact
disrupt
diginonin
show
cholesterol
particip
interact
associ
allow
tyrosin
phosphoryl
differ
protein
suggest
complex
function
ectop
express
stimul
integrindepend
motil
raji
b
cell
line
fibronectin
laminin
substrat
interfer
b
cell
differenti
modul
integrin
activ
b
cell
within
germin
center
exhibit
high
heterogen
contain
b
cell
differ
stage
differenti
b
cell
germin
center
tonsil
contain
two
distinct
popul
express
b
cell
advanc
stage
plasma
cell
differenti
interestingli
express
enhanc
affin
follicular
dendrit
cell
allow
strong
adhes
b
cell
follicular
dendrit
cell
tough
interact
contribut
better
surviv
human
germin
center
b
cell
mous
report
uniqu
marker
margin
zone
b
cell
plasma
cell
mice
defici
bruton
tyrosin
kinas
number
margin
zone
b
cell
normal
cell
plasma
cell
express
thu
express
thought
depend
signal
deriv
via
bruton
tyrosin
kinas
highlevel
express
plasma
cell
suggest
may
requir
gener
function
humor
immun
respons
howev
requir
develop
peripher
b
cell
humor
immun
b
cell
develop
activ
appear
normal
mice
ampl
evid
tetraspanin
blymphocyt
import
control
antibodi
product
immun
cell
express
differ
tetraspanin
protein
may
like
common
redund
function
plasma
cell
regulatori
b
cell
breg
specif
subtyp
b
cell
immunosuppress
properti
involv
mainten
homeostasi
immun
system
regul
inflamm
patholog
situat
although
presenc
role
breg
clearli
evidenc
differ
model
patholog
full
molecular
character
remain
elus
primarili
specif
marker
transcript
factor
identifi
date
common
marker
abil
secret
sever
group
attempt
identifi
precis
defin
b
cell
subtyp
suppress
properti
among
b
cell
other
shown
murin
b
cell
suppress
properti
b
cell
similarli
matsushita
defin
coexpress
novel
phenotyp
paramet
breg
subtyp
cell
involv
enhanc
mainten
secret
murin
human
antigenpres
cell
final
demonstr
b
cell
induc
effector
cell
growth
arrest
activ
apoptosi
via
paper
submiss
togeth
studi
provid
evid
reliabl
marker
defin
mous
human
breg
even
marker
gener
accept
literatur
yet
respect
express
lymphocyt
mice
mediat
effect
celldepend
immun
respons
tai
colleagu
search
exist
costimulatori
system
author
determin
express
almost
matur
cell
deliv
potent
costimulatori
signal
contrast
progress
cell
prolifer
induc
costimul
costimul
lead
first
prolifer
virgin
cell
second
induct
apoptosi
onceactiv
cell
activ
collig
naiv
cell
differenti
type
effector
cell
produc
produc
littl
preferenti
express
naiv
cell
subset
instrument
selfantigen
recal
antigeninduc
cell
activ
inde
inhibit
recombin
recal
antigen
tetanu
toxoidspecif
cell
prolifer
suggest
tetraspanin
play
import
role
cell
activ
pathway
also
found
associ
promin
determin
role
transmembran
extracellular
domain
associ
mutant
gene
lack
domain
construct
studi
highlight
essenti
role
particular
transmembran
domain
ligat
also
congreg
tcell
side
immunolog
synaps
lymphocyt
antigenpres
cell
support
integrinmedi
signal
modul
reloc
integrin
final
act
select
pathway
lead
membranephosphatidylserin
exposur
stimul
calcium
ionophor
act
respons
apoptot
treatment
ultraviolet
light
cycloheximid
actinomycin
extravas
leukocyt
bloodstream
site
infect
involv
complex
seri
event
depend
interact
leucocyt
apic
membran
endotheli
cell
promot
adhes
coloc
adhes
molecul
apic
endotheli
cell
surfac
reinforc
adhes
leucocyt
facilit
extravas
figur
furthermor
knockdown
result
reduct
surfac
express
thu
reduc
leucocyt
adhes
transmigr
taken
togeth
appear
key
regul
leucocyt
recruit
inflammatori
cascad
within
tem
modul
variou
virusinduc
process
membran
includ
membran
fusion
viral
bud
viral
releas
modifi
structur
organ
plastic
plasma
membran
human
immunodefici
viru
type
incorpor
specif
host
cell
protein
includ
mhc
ii
tetraspanin
present
viral
exit
site
macrophag
dendrit
cell
tcell
bud
tem
contain
tetraspanin
neg
regul
envinduc
cellcel
fusion
env
inde
knockdown
express
result
increas
syncytia
format
viral
entri
accordingli
overexpress
render
cell
less
suscept
envmedi
syncytia
format
regard
mechan
induc
hemifus
arrest
block
cellcel
fusion
transit
hemifus
pore
open
multimer
major
structur
compon
gag
plasma
membran
cluster
restrict
mobil
enhanc
virion
infect
convers
necessari
sever
coronaviru
influenza
viru
proteolyt
prime
event
viru
entri
block
blockad
also
promot
adenoassoci
viru
type
infect
involv
attach
uptak
process
viru
contact
plasmacytoid
dendrit
cell
hepat
c
virusinfect
cell
requir
antivir
immun
respons
cell
surfac
molecul
hepat
c
viru
entri
receptor
requir
recogn
hepat
c
virusinfect
cell
induc
final
mice
infect
cytopath
footandmouth
diseas
virus
rapid
specif
thymusindepend
neutral
antibodi
respons
induc
clear
viru
mechan
highlight
indic
infect
dc
stimul
innatelik
b
lymphocyt
spleen
involv
rapid
protect
footandmouth
diseas
viru
conclus
oppos
role
immun
virus
one
hand
crucial
antiinfecti
immun
hand
necessari
viru
prime
event
context
bacteri
infect
influenc
epitheli
cell
adher
neisseria
meningitidi
like
facilit
specif
receptoradhesin
engag
within
tem
also
shown
associ
integrin
membran
cofactor
protein
cofactor
act
receptor
meningococc
allow
adher
bacteri
adher
essenti
infect
antiadhes
therapi
base
use
test
express
level
cell
type
test
correl
weakli
efficaci
inhibitor
confirm
crucial
role
bacteri
adher
role
cancer
quit
controversi
express
sometim
correl
better
surviv
sometim
use
biomark
invas
late
stage
report
suppress
motil
promot
adher
lead
suppress
tumor
progress
inde
often
downregul
advanc
stage
cancer
absenc
sign
poor
prognosi
patient
lung
breast
colon
skin
ovari
uteru
stomach
oral
caviti
thyroid
prostat
hematopoiet
malign
howev
strictli
recogn
metastasi
suppressor
gene
tumor
invers
activ
observ
exampl
acut
lymphoblast
leukemia
express
indic
poor
outcom
variou
role
tetraspanin
tumor
progress
may
result
specif
tetraspanin
abund
exosom
larg
number
studi
state
role
exosom
cancer
invas
metastasi
evas
apoptosi
drug
resist
escap
immun
surveil
exosom
bear
uniqu
protein
marker
main
one
thu
surpris
one
use
marker
rang
cancer
exosom
report
tumor
biomark
function
neg
regul
lpsinduc
lung
inflamm
activ
human
macrophag
polar
regulatori
subset
interestingli
inflammatori
agent
cigarett
smoke
extract
trichostatin
downregul
express
surfac
macrophag
doubleknock
mice
spontan
develop
copdlik
phenotyp
human
express
lower
blood
monocyt
patient
copd
healthi
patient
level
even
lower
smoker
copd
healthi
smoker
field
lung
transplant
report
persist
low
level
b
cell
patient
chronic
lung
allograft
dysfunct
convers
patient
abl
restor
higher
level
b
cell
posttransplant
like
maintain
stabl
graft
function
increas
b
cell
level
month
lung
transplant
predict
longterm
surviv
patent
final
context
allerg
asthma
fewer
b
cell
spleen
lung
asthmat
mice
adopt
transfer
b
cell
alon
suffici
abrog
asthma
manner
interestingli
b
cell
present
blood
sever
asthmat
patient
paper
submiss
conclus
regul
lung
inflamm
mani
diseas
absenc
associ
variou
dysfunct
includ
bronchial
hyperreact
chronic
lung
allograft
failur
conclus
function
import
mani
diseas
involv
either
regul
mediat
diseas
figur
mani
studi
suggest
biomark
primarili
known
today
specif
exosom
marker
use
specif
tool
increas
effici
exosom
extract
method
howev
also
recogn
antiinflammatori
marker
monocyt
macrophag
inde
express
higher
type
ii
macrophag
lower
proinflammatori
nonclass
monocyt
also
describ
biomark
b
lineag
mice
uniqu
marker
margin
zone
b
cell
plasma
cell
human
marker
plasma
cell
precursor
germin
center
transcriptom
analysi
other
identifi
marker
murin
breg
cell
final
associ
b
cell
better
allograft
outcom
lung
transplant
patient
identifi
b
cell
new
predict
biomark
longterm
surviv
patent
field
cancer
suggest
biomark
metastat
clear
cell
renal
cell
carcinoma
distinguish
cancer
subtyp
also
predict
metastat
potenti
renal
cell
carcinoma
final
overexpress
esophag
squamou
cell
carcinoma
tissu
express
correl
tumor
stage
lymph
node
metastasi
opposit
end
accord
controversi
role
cancer
express
mesothelioma
tissu
correl
surviv
may
favor
prognost
marker
patient
mesothelioma
review
express
wide
varieti
hematopoiet
cell
divers
involv
regul
inflamm
thu
seem
highli
relev
consid
promis
therapeut
target
field
cancer
target
wide
studi
potenti
clinic
tool
interestingli
overexpress
glioblastoma
stem
cell
compar
express
healthi
brain
tissu
open
new
therapeut
avenu
target
glioblastoma
treatment
especi
xenotransplant
glioblastoma
stem
cell
nude
rat
promot
prolong
surviv
exosom
particip
commun
neoplast
normal
cell
suppress
immun
respons
regul
neoplast
growth
metastasi
constitu
exosom
could
potenti
target
exosomemedi
tumor
develop
proapoptot
antiprolif
properti
agonist
monoclon
antibodi
abl
pain
demonstr
vitro
human
malign
cell
line
gastric
colic
cancer
well
vivo
scid
mice
graft
malign
cell
line
taken
togeth
result
suggest
interest
use
agonist
antibodi
therapeut
tool
tetraspanin
play
role
antivir
immun
hiv
higher
express
among
cluster
differenti
observ
circul
lymphocyt
hivinfect
patient
undetect
viral
load
undergo
highli
activ
antiretrovir
therapi
result
consist
neg
regul
hiv
infect
moreov
express
higher
viral
nich
includ
macrophag
call
vcc
viru
contain
compart
argu
potenti
use
therapeut
target
biomark
viral
nich
combin
entic
strategi
could
part
cur
strategi
hiv
infect
mast
cell
belong
innat
immun
impli
numer
hypersensit
mechan
either
combin
allerg
autoimmun
inflammatori
mani
hypersensit
reaction
either
immedi
delay
impli
nonig
mediat
mast
cell
activationdegranul
tetraspanin
play
role
inde
dimer
via
crosslink
thank
mab
induc
mast
cell
degranul
dimer
suspect
coloc
plasma
membran
highaffin
ige
receptor
lead
mast
cell
activ
degranul
observ
human
basophil
rat
leukemia
cell
line
interestingli
effect
found
fab
fragment
suggest
ige
independ
activ
blockad
prevent
agig
complex
mediat
degranul
contrari
mab
block
main
hypothesi
nonig
activationdegranul
stress
role
ntal
transmembran
adaptor
protein
trap
type
ii
igg
receptor
recent
implic
igeindepend
anaphylaxi
studi
need
evalu
impact
nonigemedi
mast
cell
activationdegranul
drug
hypersensit
even
chronic
urticaria
asthmat
mice
adopt
transfer
b
cell
normal
airway
inflamm
lung
function
inhibit
inflamm
manner
restor
favor
immunolog
balanc
lung
tissu
increas
number
regulatori
b
cell
includ
breg
consider
interest
target
develop
new
therapi
regul
inflamm
asthma
allerg
diseas
induc
allergen
toler
modul
express
even
consider
autoimmun
diseas
multipl
sclerosi
block
vitro
strongli
enhanc
bloodbrain
barrier
function
reduc
migrat
monocyt
across
brain
endotheli
cell
monolay
field
respiratori
diseas
appear
neg
regul
inflamm
copd
use
molecul
statin
upregul
tetraspanin
macrophag
allow
decreas
inflamm
consider
therapeut
intervent
final
b
cell
secret
associ
better
lung
allograft
outcom
lung
transplant
creat
favor
environ
graft
reduc
inflamm
lead
chronic
lung
dysfunct
immunosuppress
treatment
anticalcineurin
mtor
inhibitor
tacrolimu
use
lung
transplant
patient
reduc
breg
subset
convers
belatacept
favor
surviv
b
cell
regulatori
properti
thu
use
immunosuppress
treatment
lungtranspl
patient
effect
breg
compart
may
essenti
maintain
level
circul
breg
reduc
risk
graft
dysfunct
final
also
test
antiadhes
properti
inhibit
bacteri
adhes
keratinocyt
shown
effect
tissueengin
model
human
skin
infect
staphylococcu
aureu
suggest
inhibitor
may
valuabl
addit
current
treatment
skin
infect
underscor
potenti
target
bacteri
infecti
diseas
conclus
express
wide
varieti
hematopoiet
cell
allow
modul
larg
rang
pathway
regul
inflamm
model
novel
immunotherapi
base
tetraspanin
modul
twofacet
strategi
inde
plasma
membran
compartment
properti
tem
primari
interest
locat
allow
modul
immun
receptor
activ
howev
ubiquit
tissu
distribut
tetraspanin
potenti
function
redund
main
obstacl
therapeut
strategi
develop
focus
tem
furthermor
depend
moleculeassoci
partner
cell
type
express
opposit
effect
nevertheless
depend
context
environ
patholog
modul
express
block
effect
seem
new
promis
therapeut
strategi
deserv
investig
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
